Literature DB >> 17171769

The classification of violence risk.

John Monahan1, Henry J Steadman, Paul S Appelbaum, Thomas Grisso, Edward P Mulvey, Loren H Roth, Pamela Clark Robbins, Stephen Banks, Eric Silver.   

Abstract

The Classification of Violence Risk (COVR) is an interactive software program designed to estimate the risk that a person hospitalized for mental disorder will be violent to others. The software leads the evaluator through a chart review and a brief interview with the patient. At the end of this interview, the software generates a report that contains a statistically valid estimate of the patient's violence risk-ranging from a 1% to a 76% likelihood of violence-including the confidence interval for that estimate, and a list of the risk factors that the program took into account to produce the estimate. In this article, the development of the COVR software is described and several issues that arise in its administration are discussed. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 17171769     DOI: 10.1002/bsl.725

Source DB:  PubMed          Journal:  Behav Sci Law        ISSN: 0735-3936


  3 in total

Review 1.  Perpetration of violence, violent victimization, and severe mental illness: balancing public health concerns.

Authors:  Jeanne Y Choe; Linda A Teplin; Karen M Abram
Journal:  Psychiatr Serv       Date:  2008-02       Impact factor: 3.084

2.  Neuroprediction, Violence, and the Law: Setting the Stage.

Authors:  Thomas Nadelhoffer; Stephanos Bibas; Scott Grafton; Kent A Kiehl; Andrew Mansfield; Walter Sinnott-Armstrong; Michael Gazzaniga
Journal:  Neuroethics       Date:  2012-04-01       Impact factor: 1.480

3.  Feasibility and Utility of Different Approaches to Violence Risk Assessment for Young Adults Receiving Treatment for Early Psychosis.

Authors:  Stephanie A Rolin; Jennifer Scodes; Renald Dambreville; Ilana R Nossel; Iruma Bello; Melanie M Wall; T Scott Stroup; Lisa B Dixon; Paul S Appelbaum
Journal:  Community Ment Health J       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.